Mr. Yu Xiaoyong
Dr. Zhenping Zhu, is our independent non-executive Director, and is responsible for supervising and providing independent advice to the Board.
Dr. Zhu has approximately 30 years of experience in the pharmaceutical industry and innovative drug research development. Prior to joining our company, Dr. Zhu had positions in various biopharmaceutical companies, including ImClone Systems, Novartis Pharma, Kadmon. Dr. Zhu also served as the president of R&D and the chief scientist of 3SBio. Currently, Dr. Zhu serves as a non-executive director at Refuge Biotechnologies, Verseau Therapeutics and Numab Therapeutics. Dr. Zhu obtained his master's degree in pharmacology from Peking Union Medical College, a Ph.D. in immunology and pathology from Dalhousie University in Canada and was a post-doctorate fellow at Genentech in the United States.